Jeff Barrett

Chief Science Officer

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Francesco Pappalardo

Full Professor

Università degli Studi di Napoli Federico II

ITALY

View details

Ramona L. Walls

Assistant Research Professor

University of Arizona

UNITED STATES

View details

Oscar Della Pasqua

UNITED KINGDOM

View details

Pieter Colin

Associate professor

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeff Barrett

Research Interests

Explore related searches

Contact this professor

Articles (10)

A Modern Curriculum for Training Scientists in Model‐Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists

Advancing the utilization of real‐world data and real‐world evidence in clinical pharmacology and translational research—Proceedings from the ASCPT 2023 preconference workshop

Moving Toward a Question‐Centric Approach for Regulatory Decision Making in the Context of Drug Assessment

The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP)

An AI Approach to Generating MIDD Assets Across the Drug Development Continuum

Opportunities for Systems Biology and Quantitative Systems Pharmacology to Address Knowledge Gaps for Drug Development in Pregnancy

Risk assessment of therapeutic agents under consideration to treat COVID‐19 in paediatric patients and pregnant women

Model‐Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children

Status Toward the Implementation of Precision Dosing in Children

A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat.

Collaborators (4)

Francesco Pappalardo

Ramona L. Walls

Oscar Della Pasqua

Pieter Colin

Make your next move.